Quarterly Result30 May 2026, 10:21 pm
ANG Lifesciences Audited Results for FY26
AI Summary
ANG Lifesciences India Ltd has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Key figures from the standalone results include revenue from operations of ₹9,160.45 lakhs for the year ended March 2026, compared to ₹8,991.01 lakhs in the previous year. The company reported a profit of ₹110.25 lakhs for the year, a significant decrease from the previous year's loss of ₹1,034.29 lakhs. The board meeting, where the results were approved, commenced at 5:00 PM and concluded at 09:50 PM on May 30, 2026.
Key Highlights
- ANG Lifesciences reports audited standalone revenue from operations of ₹9,160.45 lakhs for FY26.
- The company's standalone profit for FY26 is ₹110.25 lakhs.
- Board approved audited standalone and consolidated financial results on May 30, 2026.
- Standalone total expenses for FY26 were ₹9,752.20 lakhs.
- The results reflect figures as at March 31, 2026, compared to March 31, 2025.
Price Impact
More from ANG